Armodafinil in Binge Eating Disorder
Phase of Trial: Phase III
Latest Information Update: 18 May 2015
At a glance
- Drugs Armodafinil (Primary)
- Indications Binge-eating disorder
- Focus Registrational; Therapeutic Use
- 13 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Sep 2014 Planned End Date changed from 1 Jun 2014 to 14 Oct 2014 reported by ClinicalTrials.gov.